A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Cancer Research UK
Boston Scientific Corporation
Pfizer
Eli Lilly and Company
Inhibrx Biosciences, Inc
Cancer Research UK
Elevation Oncology
Eli Lilly and Company
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Stanford University
Revolution Medicines, Inc.
Imunon
Kyowa Kirin Co., Ltd.
Taipei Veterans General Hospital, Taiwan
University Hospital, Antwerp
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
The Second Affiliated Hospital of Fujian Medical University
Hoffmann-La Roche
Celgene
Revolution Medicines, Inc.
Jiangxi Provincial Cancer Hospital
Revolution Medicines, Inc.
Zhejiang University
Seoul National University Bundang Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gachon University Gil Medical Center
Isofol Medical AB
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Royal Marsden NHS Foundation Trust
Yale University
Novartis
Merck KGaA, Darmstadt, Germany
University Hospital, Bordeaux
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
Guangzhou Medical University
Abbott
Shandong Cancer Hospital and Institute
AVEO Pharmaceuticals, Inc.
Maria Sklodowska-Curie National Research Institute of Oncology